Eli Lilly’s Popular Weight Loss Drug, Zepbound, Is Getting a Price Cutnews2024-08-27T10:45:07+00:00August 27th, 2024|The New York Times|
Compounded Semaglutide: What to Know About Overdose Risks of Ozempic Alternativenews2024-08-06T15:00:05+00:00August 6th, 2024|The New York Times|
It’s Time to Ban Pharmaceutical Advertisingnews2024-06-19T16:21:58+00:00June 19th, 2024|The New York Times|
How Supplement Stores Are Trying to Tap Into the Ozempic Boomnews2024-04-29T23:03:41+00:00April 29th, 2024|The New York Times|
CVS and Walgreens Will Begin Selling Abortion Pills This Monthnews2024-03-01T18:37:21+00:00March 1st, 2024|The New York Times|
Abortion Shield Laws: A New War Between the Statesnews2024-02-22T21:00:41+00:00February 22nd, 2024|The New York Times|
Use of ADHD Drugs Surged During Pandemic, Study Findsnews2024-01-10T17:25:09+00:00January 10th, 2024|The New York Times|
Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealthnews2024-01-05T21:20:53+00:00January 5th, 2024|The New York Times|
Eko’s Newest CORE 500 Stethoscope: A Reviewnews2023-10-31T17:32:10+00:00October 31st, 2023|Medgadget|
FDA Issues Warning Over Misuse of Ketamine Therapynews2023-10-11T20:50:31+00:00October 11th, 2023|The New York Times|
